<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Twenty six adult patients with low grade nodular non Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL) were treated with autologous bone marrow transplantation </plain></SENT>
<SENT sid="1" pm="."><plain>Conditioning regimen was BEAM-BEAC in 15 patients and TBI + <z:chebi fb="0" ids="4027">Cyclophosphamide</z:chebi> in 11 patients </plain></SENT>
<SENT sid="2" pm="."><plain>Twenty one patients were grafted with haematopoietic stem cells, 12 after bone marrow purging and five with peripheral blood stem cells (PBSC) </plain></SENT>
<SENT sid="3" pm="."><plain>Two patients were treated in CR1 of leukemic phase, six in PR1 and eighteen in sensitive relapse </plain></SENT>
<SENT sid="4" pm="."><plain>With a median follow-up of 30 months, the actuarial survival is 91% and actuarial event free survival 67% </plain></SENT>
<SENT sid="5" pm="."><plain>These data confirm some interest of ABMT in the treatment of low grade follicular NHL </plain></SENT>
</text></document>